Science & Clinical Practice
Regenerative medicine enters a more evidence-driven phase
A RegenNews briefing on evidence, regulation and clinical translation in regenerative medicine.
Daily briefing
What you need to know today
A concise selection of what deserves your attention across news, research, regulation and practice.
01
Anvisa changes the submission process for advanced-therapy clinical research starting October 5
A new electronic form and new subject codes will be required for DDCTAs submitted by national and international…
02
Regenerative medicine enters a more evidence-driven phase
A RegenNews briefing on evidence, regulation and clinical translation in regenerative medicine.
03
Extracellular vesicles and micronized adipose tissue appear on the agenda of Europe’s advanced therapies committee
The September meeting of EMA’s Committee for Advanced Therapies included requests for scientific recommendations involving technologies directly relevant…
04
Research Briefing — critical appraisal of a clinical study
A demonstration structure for evidence, study design, findings and limitations.
05
FDA says cord-blood-derived cell product is an unapproved new drug and unlicensed biological product
A September warning letter highlights homologous use, intended use and manufacturing controls in the regulation of cellular products.
Now
View all →Latest news
International
Extracellular vesicles and micronized adipose tissue appear on the agenda of Europe’s advanced therapies committee
The September meeting of EMA’s Committee for Advanced Therapies included requests for scientific recommendations involving technologies directly relevant to regenerative medicine…
Science & Clinical Practice
Biomaterials in clinical translation: promise, evidence and regulation
A practical framework for distinguishing mechanism, evidence and regulatory status.
RESEARCH BRIEFING
Science with context, not just links
Relevant studies organized by design, evidence level, population, intervention and clinical applicability.
Explore research
DemonstrationClinical trial
Research Briefing — critical appraisal of a clinical study
A demonstration structure for evidence, study design, findings and limitations.
Official sources
See all updates →Regulatory Watch
FDA publishes a demonstration update on medical devices
Controlled example used to validate Regulatory Watch and editorial curation.
EMA issues a demonstration regulatory update
Example of an international regulatory item for the English edition.
Anvisa changes the submission process for advanced-therapy clinical research starting October 5
A new electronic form and new subject codes will be required for DDCTAs submitted by national and international developers.
FDA says cord-blood-derived cell product is an unapproved new drug and unlicensed biological product
A September warning letter highlights homologous use, intended use and manufacturing controls in the regulation of cellular products.
Innovation
View section →Technologies & devices
Technology
Demonstration regenerative device
A fictional technical profile for the technologies section.
Read analysis →Guide
How we evaluate new technologies
Market
Companies, products and ongoing studies
Regulation
Regulatory status in Brazil and other markets
RegenNews Directory
Find specialists and clinics
Structured search by field, city, region and distance. Profiles include professional identification and clear editorial criteria.
Verified profilesProfessional identification and location
PT / ENExperience designed for multiple markets
GeolocationDistance and regional relevance
Agenda
Full agenda →Featured events
27OCT2026
Congress
RegenNews Event — demonstration
A demonstration congress for agenda and regional targeting tests.